Weight Loss Medications: Mounjaro vs. Saxenda

Mounjaro and Saxenda are different medications with different approved uses. Mounjaro contains tirzepatide and is approved for type 2 diabetes. Saxenda contains liraglutide and is approved for chronic weight management in eligible patients.

When people think of weight loss medication, Ozempic may be the first one that comes to mind. It is not the only one a doctor may discuss with you.

We will compare Mounjaro vs Saxenda, two medications that come up when people explore weight loss medications.

Mounjaro vs Saxenda Similarities

Both are prescription medicines given by injection, and both act on the GLP-1 receptor. Mounjaro also acts on the GIP receptor.

Both influence appetite, food intake, and glucose regulation. They are also called incretin mimetics, which means they act like hormones the body makes.

Both products carry a boxed warning about thyroid C-cell tumors observed in rodents; the relevance to humans is unknown. Mounjaro prescribing information Saxenda prescribing information

Neither product guarantees a particular amount of weight loss, and both need a prescription and follow-up with a clinician.

What Are GIP and GLP-1 Medications?

GLP-1 is a hormone that helps the body regulate blood sugar levels and hunger. It supports the function of insulin and delays gastric emptying.

Communicating with the hypothalamus, the part of the brain controlling appetite, the medication reduces food-seeking behavior. GLP-1 agonists slow your digestion, so you feel full longer. This can reduce your cravings and calorie consumption.

In addition to acting on GLP-1, Mounjaro is also a GIP medication. GIP is a hormone the body releases when food is consumed. It helps regulate blood sugar levels.

Tirzepatide's dual receptor activity does not by itself prove it is the right option for a particular person. Evidence, health conditions, tolerability, coverage, and access all matter.

Mounjaro

The FDA has approved Mounjaro for treating type 2 diabetes. Tirzepatide, its active ingredient, is also marketed as Zepbound, which has weight-management indications. A comparison for weight treatment should distinguish that brand from Mounjaro.

This medication is a GLP-1 receptor agonist and also a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. These medicines slow gastric emptying. The slower movement of food through the digestive system is why you feel full longer.

Do not compare weight loss percentages from different trials as though participants, doses, and study conditions were identical.

Eligibility and dosing depend on the current label and an individual assessment. Mounjaro prescribing information

Medication Details

Active ingredient: Tirzepatide

Administration: Once a week by injection

Drug class: GIP and GLP-1 receptor agonist (an incretin mimetic)

Manufacturer: Eli Lilly

Purpose: Treating type 2 diabetes. The weight-management brand of tirzepatide is Zepbound.

Interactions: Tell the prescriber about pregnancy plans and all the medicines you take, including other diabetes medicines. Tirzepatide can affect oral hormonal contraceptive effectiveness around initiation and dose increases; discuss the label's contraception precautions before treatment.

Side Effects: You shouldn't take Mounjaro if you are allergic to tirzepatide or any other ingredient in the medication. It should not be used with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Gastrointestinal effects can include:

• Nausea
• Vomiting
• Diarrhea
• Constipation

Clinicians also consider pancreatitis, gallbladder disease, dehydration-related kidney problems and severe gastrointestinal conditions. Mounjaro prescribing information

If you experience side effects, even if not listed above, you should contact the prescribing physician for guidance.

What Is Off-Label?

Off-label prescribing is when a doctor writes you a prescription for a medication that is FDA-approved for a condition different than the one you are experiencing. This is a common practice and it is legal.

Whether an off-label prescription is appropriate is a decision for the prescriber, based on your health and the evidence for that use.

Saxenda

In 2014, Saxenda became the first GLP-1 agonist approved for obesity. It is approved for chronic weight management in eligible adults and adolescents aged 12 and over.

Active ingredient: Liraglutide

Administration: Once a day injection

Drug class: GLP-1 receptor agonist (an incretin mimetic)

Manufacturer: Novo Nordisk

Purpose: Chronic weight management

Interactions: Tell the prescriber about all the medicines you take, including other diabetes medicines.

People should not take Saxenda if they are allergic to liraglutide or other ingredients. People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not take Saxenda.

Side effects: Saxenda carries a boxed warning about thyroid C-cell tumors observed in rodents; the relevance to humans is unknown. Gastrointestinal effects can include:

• Nausea
• Vomiting
• Diarrhea
• Constipation

Clinicians also consider pancreatitis, gallbladder disease, dehydration-related kidney problems and severe gastrointestinal conditions. Saxenda prescribing information

There are other, less common side effects. If you experience side effects, you should contact your prescribing medical provider for advice.

Which Is Better?

The type of weight loss medication that suits you will depend on various factors. Out-of-pocket costs, insurance coverage, other medications you take, and the advice of your physician all affect the decision.

Ask which medicine is approved for your condition, what alternatives fit your health, what follow-up is needed, and what the total ongoing cost will be.

Medication should be chosen through a clinical evaluation. Convenience alone does not establish that a medicine is suitable. You can read more about getting weight loss medication online.

Online Weight Loss Medication

Now that you know how Mounjaro and Saxenda differ, you can have a more informed conversation with a prescriber.

Recovery Delivered's weight loss medications are compounded tirzepatide and compounded semaglutide. Compounded tirzepatide is not Mounjaro, Zepbound or Saxenda, compounded semaglutide is not Ozempic or Wegovy, and neither is an FDA-approved generic. Compounded products do not undergo the same FDA premarket review as approved medicines.

FDA has raised concerns about dosing errors and unapproved GLP-1 products. Ask which pharmacy is involved and what current rules allow. FDA: Concerns about unapproved GLP-1 drugs

Learn how Recovery Delivered handles prescription weight loss online.

Thinking about prescription weight loss? Recovery Delivered offers compounded tirzepatide and compounded semaglutide after an online visit with a licensed provider. Compounded medications are not FDA approved. See tirzepatide online